Maria D Ribadeneira

Title: Maria D Ribadeneira: Innovator in CNS Disease Treatment

Introduction

Maria D Ribadeneira is a prominent inventor based in Cambridge, MA. She has made significant contributions to the field of neuroscience, particularly in the treatment of central nervous system (CNS) diseases. Her innovative work focuses on the use of soluble guanylate cyclase (sGC) stimulators, which have the potential to revolutionize therapeutic approaches for various CNS disorders.

Latest Patents

Maria holds 1 patent for her groundbreaking invention titled "Treatment of CNS diseases with sGC stimulators." This patent discloses the use of sGC stimulators, along with pharmaceutically acceptable salts and formulations, for treating CNS diseases. The invention emphasizes the importance of increasing sGC stimulation, nitric oxide (NO) concentration, and cyclic guanosine 3',5'-monophosphate (cGMP) levels, or enhancing the NO pathway for effective treatment.

Career Highlights

Throughout her career, Maria has worked with notable companies in the biotechnology sector. She has been associated with Cyclerion Therapeutics, Inc. and Tisento Therapeutics Inc., where she has contributed her expertise in developing innovative therapies for CNS diseases. Her work has garnered attention for its potential impact on patient care and treatment outcomes.

Collaborations

Maria has collaborated with esteemed colleagues, including Joon Jung and Thomas Wai-Ho Lee. These partnerships have facilitated the advancement of her research and the development of her patented technologies.

Conclusion

Maria D Ribadeneira is a trailblazer in the field of CNS disease treatment, with her innovative patent showcasing the potential of sGC stimulators. Her contributions to biotechnology and collaboration with industry professionals highlight her commitment to improving therapeutic options for patients.